<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6022549</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/bty108</article-id>
    <article-id pub-id-type="publisher-id">bty108</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Systems Biology</subject>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>MARSI: metabolite analogues for rational strain improvement</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8173-2673</contrib-id>
        <name>
          <surname>Cardoso</surname>
          <given-names>João G R</given-names>
        </name>
        <xref ref-type="aff" rid="bty108-aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9984-5625</contrib-id>
        <name>
          <surname>Zeidan</surname>
          <given-names>Ahmad A</given-names>
        </name>
        <xref ref-type="aff" rid="bty108-aff2">2</xref>
        <xref ref-type="corresp" rid="bty108-cor1"/>
        <!--<email>DKAHZE@chr-hansen.com</email>-->
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jensen</surname>
          <given-names>Kristian</given-names>
        </name>
        <xref ref-type="aff" rid="bty108-aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sonnenschein</surname>
          <given-names>Nikolaus</given-names>
        </name>
        <xref ref-type="aff" rid="bty108-aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Neves</surname>
          <given-names>Ana Rute</given-names>
        </name>
        <xref ref-type="aff" rid="bty108-aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Herrgård</surname>
          <given-names>Markus J</given-names>
        </name>
        <xref ref-type="aff" rid="bty108-aff1">1</xref>
        <xref ref-type="corresp" rid="bty108-cor1"/>
        <!--<email>herrgard@biosustain.dtu.dk</email>-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Wren</surname>
          <given-names>Jonathan</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <aff id="bty108-aff1"><label>1</label>The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark</aff>
    <aff id="bty108-aff2"><label>2</label>Discovery, Chr. Hansen A/S, Hørsholm, Denmark</aff>
    <author-notes>
      <corresp id="bty108-cor1">To whom correspondence should be addressed. <email>DKAHZE@chr-hansen.com</email> or <email>herrgard@biosustain.dtu.dk</email></corresp>
    </author-notes>
    <pub-date pub-type="ppub">
      <day>01</day>
      <month>7</month>
      <year>2018</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2018-02-23">
      <day>23</day>
      <month>2</month>
      <year>2018</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>23</day>
      <month>2</month>
      <year>2018</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
    <volume>34</volume>
    <issue>13</issue>
    <issue-title>ISMB 2018 Proceedings July 6 to July 10, 2018, Chicago, IL, United States</issue-title>
    <fpage>2319</fpage>
    <lpage>2321</lpage>
    <history>
      <date date-type="received">
        <day>01</day>
        <month>9</month>
        <year>2017</year>
      </date>
      <date date-type="rev-recd">
        <day>05</day>
        <month>2</month>
        <year>2018</year>
      </date>
      <date date-type="accepted">
        <day>22</day>
        <month>2</month>
        <year>2018</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2018. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2018</copyright-year>
      <license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="bty108.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>Metabolite analogues (MAs) mimic the structure of native metabolites, can competitively inhibit their utilization in enzymatic reactions, and are commonly used as selection tools for isolating desirable mutants of industrial microorganisms. Genome-scale metabolic models representing all biochemical reactions in an organism can be used to predict effects of MAs on cellular phenotypes. Here, we present the metabolite analogues for rational strain improvement (MARSI) framework. MARSI provides a rational approach to strain improvement by searching for metabolites as targets instead of genes or reactions. The designs found by MARSI can be implemented by supplying MAs in the culture media, enabling metabolic rewiring without the use of recombinant DNA technologies that cannot always be used due to regulations. To facilitate experimental implementation, MARSI provides tools to identify candidate MAs to a target metabolite from a database of known drugs and analogues.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>The code is freely available at <ext-link ext-link-type="uri" xlink:href="https://github.com/biosustain/marsi">https://github.com/biosustain/marsi</ext-link> under the Apache License V2. MARSI is implemented in Python.</p>
      </sec>
      <sec id="s3">
        <title>Supplementary information</title>
        <p><xref ref-type="supplementary-material" rid="sup1">Supplementary data</xref> are available at <italic>Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">Novo Nordisk Foundation</named-content>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">European Union’s Horizon 2020</named-content>
        </funding-source>
        <award-id>686070</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Genome-scale metabolic models (GEMs) describe the biochemical reactions in an organism and their relation to the proteome and genome (<xref rid="bty108-B6" ref-type="bibr">McCloskey <italic>et al.</italic>, 2013</xref>). These models comprehensively represent natural metabolism and they are useful for predicting the effect of metabolite analogues (MAs) as therapeutics (<xref rid="bty108-B1" ref-type="bibr">Agren <italic>et al.</italic>, 2014</xref>; <xref rid="bty108-B5" ref-type="bibr">Kim <italic>et al.</italic>, 2014</xref>).</p>
    <p>Non-rational strategies such as mutagenesis and selection or laboratory evolution can be used to develop industrial strains when the use of recombinant DNA technology is not allowed due to regulations (<xref rid="bty108-B2" ref-type="bibr">Derkx <italic>et al.</italic>, 2014</xref>; <xref rid="bty108-B3" ref-type="bibr">Hansen <italic>et al.</italic>, 2017</xref>). MAs, inhibiting the enzymatic conversion of the target metabolite, act as metabolite knockouts and can be used as the selective pressure in non-rational strategies to shape the metabolism of microorganisms (<xref rid="bty108-B11" ref-type="bibr">Sørensen <italic>et al.</italic>, 2016</xref>).</p>
    <p>Here, we present software that implements workflows to identify metabolite knockouts instead of gene or reaction knockouts (<xref ref-type="fig" rid="bty108-F1">Figure 1A</xref>). We also provide a pipeline to identify structural analogues for those targets.</p>
  </sec>
  <sec>
    <title>2 Materials and methods</title>
    <p>The first workflow consists of systematically replacing reaction knockouts (identified by other strain design methods) by metabolite knockouts, until we can find metabolite targets that result in a similar flux distribution. The second workflow consists of searching for metabolite targets using heuristic optimization, without the need to specify reaction knockouts a priori. A metabolite knockout consists of blocking all reactions consuming a given metabolite, excluding transporters.</p>
    <p>After identifying the metabolite targets, we search for MAs similar to them. We compiled a database of potential MAs from publicly available sources (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref>). We use OpenBabel (<xref rid="bty108-B7" ref-type="bibr">O’Boyle <italic>et al.</italic>, 2011</xref>) and <xref rid="bty108-B10" ref-type="bibr">RDKit (2017</xref>) (<ext-link ext-link-type="uri" xlink:href="http://www.rdkit.org">http://www.rdkit.org</ext-link>) to calculate the features used to compare candidate MAs to the target metabolite: number of atoms/bonds/rings, MACCs fingerprints, Tanimoto coefficient (TC) and structural similarity score (SS).</p>
  </sec>
  <sec>
    <title>3 Results</title>
    <p>We implemented a software package containing algorithms to generate strain design strategies using MAs. Our software could generate metabolite targets for a published knockout-based design (<xref rid="bty108-B4" ref-type="bibr">Harder <italic>et al.</italic>, 2016</xref>). We also provide the tools to identify candidate MAs that could be used for implementation of the designs.</p>
    <sec>
      <title>3.1 Identification of replacement targets</title>
      <p>We used an experimentally validated strain design for itaconic acid production in <italic>Escherichia coli</italic> (<xref rid="bty108-B4" ref-type="bibr">Harder <italic>et al.</italic>, 2016</xref>) and the <italic>E.coli</italic> GEM iJO1366 (Orth <italic>et al.</italic>, 2014) to demonstrate the use of MARSI. MARSI identified acetyl-phosphate as a metabolite knockout target that can replace the Phosphotransacetylase (PTAr) reaction knockout and sustain the same flux for itaconic acid production (<xref rid="bty108-T1" ref-type="table">Table 1</xref>). Using a SS cut-off of 0.5 (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref>), we found 182 MAs for acetyl-phosphate (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1</xref> shows the top 10 hits). More examples of replacement targets in other <italic>E.coli</italic> strain designs can be found in <xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref>.
<table-wrap id="bty108-T1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Knockout replacements for the strain design</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Non-replaced knockouts</th><th rowspan="1" colspan="1">Replaced reaction</th><th rowspan="1" colspan="1">Metabolite</th><th rowspan="1" colspan="1">Original fitness</th><th rowspan="1" colspan="1">New fitness</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">PTA2, ICL, ALDD2x, PYK, SUCOAS, GGGABADr</td><td rowspan="1" colspan="1">PTAr</td><td rowspan="1" colspan="1">Acetyl-P</td><td rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1">0.001</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>We use Biomass Product Coupled Yield (<xref rid="bty108-B9" ref-type="bibr">Patil <italic>et al.</italic>, 2005</xref>) as fitness measure. Reaction Ids: Phosphate acetyltransferase (PTA), Isocitrate lyase (ICL), Aldehyde dehydrogenase (ALDD2x), Pyruvate kinase (PK), Succinyl-CoA synthetase (SUCOAS) and Gamma-glutamyl-gamma aminobutyric acid dehydrogenase (GGGABADr).</p></fn></table-wrap-foot></table-wrap></p>
    </sec>
    <sec>
      <title>3.2 Query calibration with known MAs</title>
      <p>In order to validate the ability of MARSI to find known analogues for a target metabolite, we selected 42 known metabolite-MA pairs from the literature (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S3</xref>). We compared the structural features between the MAs and their target metabolites (<xref ref-type="supplementary-material" rid="sup1">Supplementary Fig. S1</xref>). We used a distance of 4 for the number of atoms, 3 for the number of bonds and 2 for the number of rings as our query cut-off. The TC cut-off changes dynamically with the size of the metabolites (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref>). In <xref ref-type="fig" rid="bty108-F1">Figure 1B</xref>, we show the SS and TC for different targets and their known analogues as well as the best hit analogue in the database. For most targets MARSI found candidate MAs that showed higher structural similarity to the target metabolite than the known analogue.
</p>
      <fig id="bty108-F1" orientation="portrait" position="float">
        <label>Fig. 1.</label>
        <caption>
          <p>Metabolite target identification workflow and examples of MA targets. <bold>(A)</bold> The workflow for identifying for metabolite knockouts and candidate MAs. <bold>(B)</bold> Comparison between the known MAs (columns 1 and 2) and the best MARSI hits (columns 3 and 4) used to calibrate the search parameters. We show the TC and the SS. We highlighted rows where the best MARSI hit and the known MA are the same</p>
        </caption>
        <graphic xlink:href="bty108f1"/>
      </fig>
    </sec>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sup1">
      <label>Supplementary Data</label>
      <media xlink:href="bty108_supplementary_materials_revision.docx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack>
    <title>Acknowledgements</title>
    <p>We would like to thank Miguel Campodonico for input on chemoinformatics tools.</p>
    <sec>
      <title>Funding</title>
      <p>This work has been supported by the Novo Nordisk Foundation. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 686070.</p>
      <p><italic>Conflict of Interest</italic>: none declared.</p>
    </sec>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="bty108-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agren</surname><given-names>R.</given-names></name></person-group><etal>et al</etal> (<year>2014</year>) 
<article-title>Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling</article-title>. <source>Mol. Syst. Biol</source>., <volume>10</volume>, <fpage>721</fpage>–<lpage>721</lpage>.<pub-id pub-id-type="pmid">24646661</pub-id></mixed-citation>
    </ref>
    <ref id="bty108-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Derkx</surname><given-names>P.M.</given-names></name></person-group><etal>et al</etal> (<year>2014</year>) 
<article-title>The art of strain improvement of industrial lactic acid bacteria without the use of recombinant DNA technology</article-title>. <source>Microb. Cell. Fact.</source>, <volume>13</volume>(Suppl. 1), S5.</mixed-citation>
    </ref>
    <ref id="bty108-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hansen</surname><given-names>A.S.L.</given-names></name></person-group><etal>et al</etal> (<year>2017</year>) 
<article-title>Systems biology solutions for biochemical production challenges</article-title>. <source>Curr. Opin. Biotechnol</source>., <volume>45</volume>, <fpage>85</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">28319856</pub-id></mixed-citation>
    </ref>
    <ref id="bty108-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harder</surname><given-names>B.-J.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>Model-based metabolic engineering enables high yield itaconic acid production by Escherichia coli</article-title>. <source>Metab. Eng</source>, <volume>38</volume>, <fpage>29</fpage>–<lpage>37</lpage>.<pub-id pub-id-type="pmid">27269589</pub-id></mixed-citation>
    </ref>
    <ref id="bty108-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H.U.</given-names></name></person-group><etal>et al</etal> (<year>2014</year>) 
<article-title>Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery</article-title>. <source>Mol. Syst. Biol</source>., <volume>7</volume>, <fpage>460</fpage>–<lpage>460</lpage>.</mixed-citation>
    </ref>
    <ref id="bty108-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCloskey</surname><given-names>D.</given-names></name></person-group><etal>et al</etal> (<year>2013</year>) 
<article-title>Basic and applied uses of genome-scale metabolic network reconstructions of Escherichia coli</article-title>. <source>Mol. Syst. Biol</source>., <volume>9</volume>, <fpage>661</fpage>.<pub-id pub-id-type="pmid">23632383</pub-id></mixed-citation>
    </ref>
    <ref id="bty108-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O’Boyle</surname><given-names>N.M.</given-names></name></person-group><etal>et al</etal> (<year>2011</year>) 
<article-title>Open Babel: an Open chemical toolbox</article-title>. <source>J. Cheminform</source>., <volume>3</volume>, <fpage>1</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">21214931</pub-id></mixed-citation>
    </ref>
    <ref id="bty108-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Orth</surname><given-names>J.D.</given-names></name></person-group><etal>et al</etal> (<year>2011</year>) 
<article-title>A comprehensive genome-scale reconstruction of Escherichia coli metabolism–2011</article-title>. <source>Mol. Syst. Biol</source>., <volume>7</volume>, <fpage>535</fpage>.<pub-id pub-id-type="pmid">21988831</pub-id></mixed-citation>
    </ref>
    <ref id="bty108-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patil</surname><given-names>K.R.</given-names></name></person-group><etal>et al</etal> (<year>2005</year>) 
<article-title>Evolutionary programming as a platform for in silico metabolic engineering</article-title>. <source>BMC Bioinformatics</source>, <volume>6</volume>, <fpage>308</fpage>.<pub-id pub-id-type="pmid">16375763</pub-id></mixed-citation>
    </ref>
    <ref id="bty108-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>RDKit.</surname></name></person-group> (<year>2017</year>) 
<article-title>Cheminformatics and machine Learning Software</article-title>. <ext-link ext-link-type="uri" xlink:href="http://www.rdkit.org">http://www.rdkit.org</ext-link> (31 August 2017, date last accessed)</mixed-citation>
    </ref>
    <ref id="bty108-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sørensen</surname><given-names>K.I.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>Enhancing the sweetness of yoghurt through metabolic remodeling of carbohydrate metabolism in Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus</article-title>. <source>Appl. Environ. Microbiol</source>., <volume>82</volume>, <fpage>3683</fpage>–<lpage>3616</lpage>.<pub-id pub-id-type="pmid">27107115</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
